Prime Medicine Depreciation & Amortization Growth & History (PRME)
Prime Medicine's depreciation and amortization was $7.3M for fiscal 2025.
View full Prime Medicine company overviewPrime Medicine annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $7.3M | $1.2M | +19.47% |
| 2024 | 2024-12-31 | $6.1M | $1.5M | +31.70% |
| 2023 | 2023-12-31 | $4.7M | $2.4M | +109.22% |
| 2022 | 2022-12-31 | $2.2M | $1.7M | +291.55% |
| 2021 | 2021-12-31 | $568,000 | $525,000 | +1220.93% |
| 2020 | 2020-12-31 | $43,000 | — | — |
Prime Medicine quarterly depreciation and amortization
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.8M | −$79,000 | −4.24% |
| Q1 2026 | 2026-03-31 | $1.9M | $156,000 | +9.18% |
| Q4 2025 | 2025-12-31 | $1.9M | — | — |
| Q3 2025 | 2025-09-30 | $1.9M | $323,000 | +20.73% |
| Q2 2025 | 2025-06-30 | $1.9M | $326,000 | +21.20% |
| Q1 2025 | 2025-03-31 | $1.7M | $385,000 | +29.28% |
| Q3 2024 | 2024-09-30 | $1.6M | $322,000 | +26.05% |
| Q2 2024 | 2024-06-30 | $1.5M | $420,000 | +37.57% |
| Q1 2024 | 2024-03-31 | $1.3M | $263,000 | +25.00% |
| Q3 2023 | 2023-09-30 | $1.2M | $605,000 | +95.88% |
| Q2 2023 | 2023-06-30 | $1.1M | $688,000 | +160.00% |
| Q1 2023 | 2023-03-31 | $1.1M | $759,000 | +259.04% |
| Q3 2022 | 2022-09-30 | $631,000 | $431,000 | +215.50% |
| Q2 2022 | 2022-06-30 | $430,000 | — | — |
| Q1 2022 | 2022-03-31 | $293,000 | — | — |
| Q3 2021 | 2021-09-30 | $200,000 | — | — |
Prime Medicine depreciation and amortization trends
Over the last five fiscal years, Prime Medicine's depreciation and amortization increased from $43,000 to $7.3M, a change of $7.3M. The latest reported quarter, Q2 2026, shows $1.8M.
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Prime Medicine source filings ↗